Cargando…
Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473480/ https://www.ncbi.nlm.nih.gov/pubmed/34586736 http://dx.doi.org/10.1002/ctm2.547 |
| _version_ | 1784575000802492416 |
|---|---|
| author | Kunzke, Thomas Hölzl, Fabian T. Prade, Verena M. Buck, Achim Huber, Katharina Feuchtinger, Annette Ebert, Karolin Zwingenberger, Gwen Geffers, Robert Hauck, Stefanie M. Haffner, Ivonne Luber, Birgit Lordick, Florian Walch, Axel |
| author_facet | Kunzke, Thomas Hölzl, Fabian T. Prade, Verena M. Buck, Achim Huber, Katharina Feuchtinger, Annette Ebert, Karolin Zwingenberger, Gwen Geffers, Robert Hauck, Stefanie M. Haffner, Ivonne Luber, Birgit Lordick, Florian Walch, Axel |
| author_sort | Kunzke, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8473480 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84734802021-10-01 Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer Kunzke, Thomas Hölzl, Fabian T. Prade, Verena M. Buck, Achim Huber, Katharina Feuchtinger, Annette Ebert, Karolin Zwingenberger, Gwen Geffers, Robert Hauck, Stefanie M. Haffner, Ivonne Luber, Birgit Lordick, Florian Walch, Axel Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-09-26 /pmc/articles/PMC8473480/ /pubmed/34586736 http://dx.doi.org/10.1002/ctm2.547 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Kunzke, Thomas Hölzl, Fabian T. Prade, Verena M. Buck, Achim Huber, Katharina Feuchtinger, Annette Ebert, Karolin Zwingenberger, Gwen Geffers, Robert Hauck, Stefanie M. Haffner, Ivonne Luber, Birgit Lordick, Florian Walch, Axel Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer |
| title | Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer |
| title_full | Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer |
| title_fullStr | Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer |
| title_full_unstemmed | Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer |
| title_short | Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer |
| title_sort | metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with her2‐positive advanced gastric cancer |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473480/ https://www.ncbi.nlm.nih.gov/pubmed/34586736 http://dx.doi.org/10.1002/ctm2.547 |
| work_keys_str_mv | AT kunzkethomas metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT holzlfabiant metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT pradeverenam metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT buckachim metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT huberkatharina metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT feuchtingerannette metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT ebertkarolin metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT zwingenbergergwen metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT geffersrobert metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT hauckstefaniem metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT haffnerivonne metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT luberbirgit metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT lordickflorian metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer AT walchaxel metabolomictherapyresponsepredictioninpretherapeutictissuebiopsiesfortrastuzumabinpatientswithher2positiveadvancedgastriccancer |